Primary Record
tetragastrin
Note: Only for scientific research or as raw materials for production.
- In stock
- 611 g
- Purity
- 99.7 %
- CAS
- 1947-37-1
Compound Identifiers & Properties
- CAS
- 1947-37-1
- PubChem CID
- 446569
- SMILES
- CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N
- Canonical SMILES
- CSCC[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Names & Synonyms
- tetragastrin
- Gastrin tetrapeptide
- Gatratet
- Cholecystokinin 4
- Cholecystokinin tetrapeptide
- AOC-tetragastrin
- AOC Tetragastrin
- AOC Tetrapeptide
- AOC-Tetrapeptide
- cholecystokinin-4
- Tetragastrin [JAN]
- 1947-37-1
- CCK-4
- Gastrin tetrapeptide amide
- Tetragastrin (JAN)
- Tetrapeptide, Gastrin
- trp-met-asp-phe amide
- H-Trp-Met-Asp-Phe-NH2
- Cholecystokinin 30-33
- AC1L9JTO
- Tetragastrin hydrochloride
- RefChem:188595
- CCRIS 3246
- Cholecystokinin(30-33)
- H-WMDF-NH2
- 4-7-cholecystokinin-7 (swine)
- Cholecystokinin-Tetrapeptide
- CHEMBL120632
- Cholecystokinin (30-33)
- Gastrin(14-17)(human)
- Tetragastrin (hydrochloride)
- Trp-Met-Asp-Phe-NH(2)
- 0OL293AV80
- CKK-4
- WMDF-NH(2)
- TETRAGASTRIN [WHO-DD]
- UNII-0OL293AV80
- CHEBI:137728
- MFCD00076492
- SCHEMBL9710792
- C29H36N6O6S
- CHEBI:32210
- Carbobenzoxy-trp-met-asp-phe-amide
- DTXSID601027522
- ZINC4217536
- BDBM50024317
- CID446569
- EX-A11253
- L-Trp-L-Met-alpha-Asp-L-Phe amide
- L-Trp-L-Met-L-Asp-L-Phe-NH(2)
- AKOS040744602
- Cholecystokinin C-terminal tetrapeptide
- Cholecystokinin Fragment 30-33 Amide
- BAT-015449
- CCK(30-33)
- CCK (30-33)
- FG108885
- MS-30582
- HY-125556
- J128.630G
- Cholecystokinin, CCK Tetrapeptide (30-33)
- CS-0092217
- D01456
- SR-01000883973
- A1016031
- SR-01000883973-1
- BRD-K70369756-001-01-3
- L-Triptophyl-L-methyionyl-L-alpha-aspartyl-L-phenylalaninamide
- L-tryptophyl-L-methionyl-L-aspartylphenyl-Alaninamide
- (3S)-3-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid
- 35144-91-3
- Cholecystokinin Fragment 30-33 Amide, >=95% (HPLC)
- L-Phenylalaninamide, L-tryptophyl-L-methionyl-L-alpha-aspartyl-
- L-tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide
- L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide
- (3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid
- (S)-4-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-3-((S)-2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)-4-(methylthio)butanamido)-4-oxobutanoic acid
- L-PHENYLALANINAMIDE, L-TRYPTOPHYL-L-METHIONYL-L-.ALPHA.-ASPARTYL-
- L-Phenylalaninamide, N-((phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-
- N-((Phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide
- (3S)-3-(((2S)-2-(((2S)-2-amino-3-(1H-indol-3-yl)propanoyl)amino)-4-methylsulfanylbutanoyl)amino)-4-(((2S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid
- (3S)-3-((2S)-2-((2S)-2-amino-3-(1H-indol-3-yl)propanamido)-4-(methylsulfanyl)butanamido)-3-(((1S)-1-carbamoyl-2-phenylethyl)carbamoyl)propanoic acid
- (3S)-4-[[(1S)-2-amino-1-benzyl-2-oxo-ethyl]amino]-3-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanyl-butanoyl]amino]-4-oxo-butanoic acid
- 3-{2-[2-Amino-3-(1H-indol-3-yl)-propionylamino]-4-methylsulfanyl-butyrylamino}-N-(1-carbamoyl-2-phenyl-ethyl)-succinamic acid
- 5609-49-4